Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
NCT02438904Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2015
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in poor graft function (PGF), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Increased Graft Function after Stem Cell Transplantation (SCT) at 4 weeks. Started May 2015; status: recruiting.
02
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT02438904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438904.